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The nigrostriatal neurotoxin N-methyl-1,2,3,6_tetrahydropyridine (MPTP) causes Parkinsonism in humans 
and laboratory animals. MPTP neurotoxicity is dependent on its oxidation to N-methyl-4-phenylpyridine 
(MPP+). The mechanism by which MPP+ causes destruction of dopamine-containing nigrostriatal cells is 
unknown. Here we show that MPP+ but not MPTP is taken up by energized mitochondria. MPP+ in the 
presence of dopamine and particularly of 6-hydroxydopamine stimulates Caz+ release from mitochondria. 
CaZ+ release is accompanied by hydrolysis of intramitochondrial pyridine nucleotides. Our findings suggest 
that the MPTP-induced model of Parkinson’s disease may be due to a disturbed Ca*+ homeostasis in do- 
pamine neurons. 
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1. INTRODUCTION 
MPTP produces a chemically induced model of 
Parkinson’s disease in primates by selective 
destruction of dopamine-containing cells in the 
nigrostriatal tract of the brain [l]. MPTP is 
metabolized by brain monoamine oxidase type B 
to N-methyl-4-phenyl-2,3_dihydropyridine which 
is further oxidized to MPP+ [2-41. MPP+ is then 
selectively taken up into dopamine neurons [5,6]. 
This paper is dedicated to Professor C. Martius on the 
occasion of his 80th birthday 2. MATERIALS AND METHODS 
* To whom correspondence should be addressed 2.1. Materials 
Abbreviations: arsenazo III, 2,2’-(1,8-dihydroxy- 
3,6-disulphonaphthalene-2,7-bis azo)bis(benzenearsonic 
acid); CCCP, carbonyl cyanide m-chlorophenylhydra- 
zone; A$, mitochondrial transmembrane electrical 
potential, negative inside; MPP+, N-methyl-4-phenyl- 
pyridine; MPTP, N-methyl-1,2,3,6_tetrahydropyridine; 
6-OHDA, 6-hydroxydopamine 
MPP+ and MPTP were obtained from Research 
Biochemicals (Wayland); N-[methyl-‘H]MPP+, N- 
[methyl-3H]MPTP and 4’CaC12 from New 
England Nuclear; [carboxyl-‘4C]nicotinic acid 
from The Radiochemical Centre, Amersham; 
arsenazo III, dopamine and 6-OHDA from Fluka, 
Buchs .
Once inside the neuron the mechanism by which 
MPP+ exerts its neurotoxicity is not known. It has 
been speculated that the culprit is a cocktail of ox- 
idation products derived from dopamine and 
MPTP. Since oxidative stress induces release of 
Ca*+ from mitochondria [7-lo], and since distur- 
bance of cellular Ca*+ homeostasis upon release of 
mitochondrial Ca*+ can cause cell death [ 11,121, 
we investigated the ability of mitochondria to re- 
tain Ca*+ in the presence of MPTP, MPP+, 
6-OHDA and dopamine. 
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2.2. Isolation of liver miiochondria 
Liver mitochondria of female Wistar rats fasted 
overnight were isolated as in [13]. ~itochondria 
were washed twice in 210 mM mannitol, 70 mM 
sucrose, 5 mM Hepes, pH 7.4 (MSH buffer). 
2.3. Standard incubation procedure 
Mitochondria (2 mg protein/ml) were incubated 
at 25°C in 3 ml MSH buffer under constant stir- 
ring and oxygenation. Reduction of mitochondrial 
pyridine nucleotides and release of endogenous 
Ca2+ were induced by addition of 5 FM rotenone. 
Thereafter, when appropriate, Ca2+ was added or, 
to prevent possible reuptake of Ca’+, EGTA was 
added. Mitochondria were then energized with 
2.5 mM K+-succinate. When appropriate, Ca*+ 
uptake was allowed to proceed for 2 min. The final 
Ca*+ loads given in section 3 are the sum of the en- 
dogenous and added Ca*+. Finally, 0.5 mM 
MPP+, MPTP, or 6-OHDA were added (time 
zero). 
2.4. Determination of intramitochondrial 
radioactivity 
Mitochondria were incubated in the presence of 
the appropriate radioactive compound ([‘HI- 
MPP+, [3H]MPTP, 45Ca2+, or r4C-labeled 
intr~itochondrial pyridine nucleotides). At the 
times indicated I50-~1 aliquots were withdrawn, 
filtered through Millipore filters (0.45 pm pore 
size), and rinsed twice with 150~1 cold MSH buf- 
fer. The radioactivity remaining on the filters was 
determined in a liquid scintillation counter. 
2.5. Spectrophotometric determination of Cd’ 
uptake and release by mitochondria 
Measurements were made in the presence of 
50gM arsenazo III at 685-675 nm. 
3. RESULTS AND DISCUSSION 
Energized mitochondria take up MPP+ but not 
MPTP (fig.1). With both 100/1M (not shown) and 
5OOpM MPP+ (fig.la), 24070, i.e. 12 or 
60 nmol/mg protein, of the offered MPP+ is taken 
up. The uptake of MPP+ is prevented by the un- 
coupler CCCP; likewise, accumulated MPP+ is 
released instantaneously upon addition of CCCP 
(fig.la). It is well known that Ca*+ is taken up by 
mitochondria electrophoretically and thereby 
100 
TIME (mm) 
Fig.1. Uptake of MPP+ and MPTP by mitochondria. 
Mitochondria were incubated under standard 
conditions, and (b only) depleted of Ca” or loaded with 
58 nmol Ca’+/mg protein. At zero time, 0.5 mM N- 
[merhyl-‘H]MPP+ (spec. act. 470 dpm/nmol) or N- 
[methyC3H]MPTP (485 dpm/nmol) was added. Uptake 
of radioactivity was determined by Millipore filtration. 
(a) [3H]MPP+ (0); [3H]MPTP (m); [3H]MPPt and, at 
the arrows, Ca2+ (8 nmol/mg protein) or 2.0 /cM CCCP 
(e); 2.0 pM CCCP added before MPP+ (0). (b) 
[3H]MPP+ added to Ca’+-depleted mitochondria (0); 
13H]MPPt added to Ca*+-loaded mitochondria (m); 
13H]MPP+ together with 0.5 mM 6-OHDA added to 
Ca2’-loaded mito~hondria (0 ). 
lowers the mitochondrial transmembrane poten- 
tial, negative inside (A#). When Ca*+ is added to 
energized mitochondria before MPP+ uptake is 
completed, further accumulation of MPP+ is 
prevented (fig.la). Fig.lb shows that Ca2+- 
depleted mitochondria take up more MPP+ than 
Ca*+-loaded mitochondria. When MPP+ is added 
together with 6-OHDA to Ca*+-loaded mitochon- 
dria the initial rate of MPP+ uptake is the same as 
in the absence of 6-GHDA. However, MPP+ up- 
take is now soon followed by MPP+ release due to 
increased Ca2’ cycling (see below). The above 
observations indicate that MPP+ equilibrates in 
response to A+ between the intra- and 
extramitochondrial compartment. 
When MPP+ or 6-OHDA is added to 
Ca*+-loaded mitochondria in the absence of 
EGTA, i.e. when in principle Ca*+ reuptake can 
take place after Ca*+ release (‘Ca*+ cycling’), a 
pronounced net Ca*+ release is observed only after 
about 15 min (fig.2a). In contrast, when MPP+ 
and 6-OHDA are added jointly a rapid and virtual- 
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Fig.2. Release of Ca’+ from mitochondria in the 
presence of MPP+, MPTP and 6-OHDA. Mitochondria 
were incubated under standard conditions and loaded 
with 58 nmol Ca’+/mg protein. Ca*+ movements were 
followed either (a) sp~trophotometrically or (b) by 
Millipore filtration and 45ca2+ (spec. act. 
1100 dpm/nmol). At zero time the following additions 
(0.5 mM) were made: (a) MPP+ (curve a); 6-OHDA 
(curve b); MPP+ together with 6-OHDA (curve c); 
MPTP together with 6-OHDA (curve d); MPP+ and 
MPTP together with 6-OHDA (curve e). (b) EGTA ( q ); 
EGTA and MPP+ (0); EGTA and 6-OHDA (0); EGTA 
together with MPP+ and 6-OHDA (m). (Inset) 
Difference between curves ( q ) and ( n ). 
Iy complete Ca*+ release ensues almost instan- 
taneously (fig.2a). This rapid release is paralleled 
by increased Ca*+ cycling and consequently a fall 
of Afi as measured by the safranine technique [141 
(not shown). MPTP inhibits the GOHDA- 
stimulated Ca*+ release and diminishes the effec- 
tiveness of MPP+ and 6-OHDA in stimulating 
Ca*+ release (fig.2a). Also dopamine, albeit less ef- 
fectively than 6-OHDA, stimulates Ca*+ release 
from mitochondria in the absence of EGTA the 
onset of which is much earlier in the presence of 
MPP+ (not shown). When Ca’* release is 
measured under non-cycling conditions due to the 
presence of EGTA (fig.2b) stimulated release is 
observed only when MPP+ and 6-OHDA are of- 
fered together to mitochondria. The stimulation is 
transient under these conditions (cf. inset to 
fig.2b). 
Ca2’ release can be the result of a collapsed A# 
due to mitochondrial damage. MPP+ added to 
Ca2+-depleted mitochondria energized by K”- 
succinate does not alter A$ (not shown). Ca2+ 
release as a result of damage caused by MPP+ is 
therefore ruled out. 
The oxidation and subsequent hydrolysis of 
mitochondrial pyridine nucleotides have been im- 
plicated to be important in the Ca*+-release 
mechanism of mitochondria [8-10). MPP+ might 
be reduced in mitochondria, and 6-OHDA can 
auto-oxidize [15] and form Hz02 which is reduced 
in mitochondria enzymatically by NAD(P)H 
[8-lo]. We therefore investigated MPP+- and 
6-OHDA-induced pyridine nucleotide hydrolysis 
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Fig.3. Hydrolysis of mitochondrial pyridine nucleotides 
induced by MPP” and 6-OHDA. Intramitochondrial 
pyridine nucleotides were labeled in vivo at the 
nicotinamide moiety [Y]. Mitochondria were incubated 
under standard conditions and loaded with 58 nmol 
Ca’+/mg protein. At zero time the following additions 
(0.5 mM) were made: MPP+ (0); 6-OHDA (0); MPP+ 
and 6-OHDA (0); MPP+ together with 6-OHDA and 
EGTA (m). Release of intramitochondrial radioactivity, 
indicating pyridine nucleotide hydrolysis [9], was 
followed by Millipore filtration. 
I01 
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in mitochondria (fig.3). MPP+ alone does not 
cause pyridine nucleotide hydrolysis in Ca’+- 
loaded mitochondria. About 50% of pyridine 
nucleotides are hydrolyzed within 20 min in the 
presence of 6-OHDA whereas in the presence of 
both MPP+ and 6-OHDA hydrolysis is almost 
complete at this time. In the presence of EGTA 
pyridine nucleotide hydrolysis induced by MPP+ 
together with 6-OHDA in Ca’+-loaded mitochon- 
dria is less extensive and follows a similar time 
course to Ca2+ release under identical conditions 
(cf. fig.2b). It is therefore likely that the MPP+- 
and 6-OHDA-stimulated Ca2+ release takes place 
by a mechanism linked to pyridine nucleotide ox- 
idation and hydrolysis [&lo]. 
The present results demonstrate that MPP+ in 
combination with 6-OHDA or dopamine, but not 
alone, greatly decreases the ability of mitochondria 
to retain Ca2+. Whether this is due to the stimula- 
tion of a specific Ca2+ -release mechanism or to 
unspecific damage of mitochondria remains un- 
known. Disturbance of cellular Ca2+ homeostasis 
upon release of Ca2+ from mitochondria can cause 
cell death [ 11,121. Our findings provide experimen- 
tal support for the hypothesis that a cocktail of ox- 
idation products of both dopamine and MPTP are 
important for the development of the MPTP- 
induced model of Parkinson’s disease and suggest 
that destruction of nigrostriatal cells may be due to 
disturbed Ca2+ homeostasis. 
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